Kimia Biosciences informs about updates

29 Apr 2020 Evaluate

Kimia Biosciences has informed that the Company has been granted permission to Manufacturing and Marketing of New Active pharmaceutical Ingredient Azelnidipine drug by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare, FDA Bhawan, New Delhi - 110002 (India) Vide permission No. MF/SND/20/000114 dated 28-April-2020 in FORM CT-22 under Drugs & Cosmetics Acts & Rules thereunder.

The above information is a part of company’s filings submitted to BSE.



Kimia Biosciences Share Price

30.01 -0.98 (-3.16%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×